| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |